Cargando…

Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning

INTRODUCTION: In planning for the introduction of vaginal microbicides and other new antiretroviral (ARV)-based prevention products for women, an in-depth understanding of potential end-users will be critically important to inform strategies to optimize uptake and long-term adherence. User-centred p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Amy H, Breger, Tiffany L, Barnhart, Matthew, Kim, Ann, Vangsgaard, Charlotte, Harris, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Women and ARV-based prevention: opportunities and challenges
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163992/ https://www.ncbi.nlm.nih.gov/pubmed/25224619 http://dx.doi.org/10.7448/IAS.17.3.19162

Ejemplares similares

Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction
por: Lanham, Michele, et al.
Publicado: (2014)

Communicating about microbicides with women in mind: tailoring messages for specific audiences
por: Sidibe, Sekou, et al.
Publicado: (2014)

Community and research staff collaboration for development of materials to inform microbicide study participants in Africa
por: Woodsong, Cynthia, et al.
Publicado: (2014)

The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study
por: Mack, Natasha, et al.
Publicado: (2014)

Women and ARV-based prevention: opportunities and challenges
por: Geary, Cynthia W, et al.
Publicado: (2014)

Comparing patterns of sexual risk among adolescent and young women in a mixed-method study in Tanzania: implications for adolescent participation in HIV prevention trials
por: Tolley, Elizabeth E, et al.
Publicado: (2014)

Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa
por: van der Straten, Ariane, et al.
Publicado: (2014)

Women and ARV-based HIV prevention – challenges and opportunities
por: Geary, Cynthia W, et al.
Publicado: (2014)

WHO guidance grounded in a comprehensive approach to sexual and reproductive health and human rights: topical pre-exposure prophylaxis
por: Lusti-Narasimhan, Manjula, et al.
Publicado: (2014)

An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings
por: MacQueen, Kathleen M, et al.
Publicado: (2014)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa
por: Corneli, Amy L, et al.
Publicado: (2014)

Distribution and characterization of microplastics in marine sediments from the Montenegrin coast
por: Bošković, Neda, et al.
Publicado: (2022)

The impact of COVID-19 on tuberculosis: challenges and opportunities
por: Kant, Surya, et al.
Publicado: (2021)

Bronchial brushing Xpert improves the diagnostic efficiency of sputum Xpert in patients with pulmonary tuberculosis
por: He, Yu, et al.
Publicado: (2021)

The role of bronchoscopy in the diagnosis and management of pediatric pulmonary tuberculosis
por: Goussard, Pierre, et al.
Publicado: (2021)

Development of a nomogram for predicting treatment default under facility-based directly observed therapy short-course in a region with a high tuberculosis burden
por: Wang, Saibin
Publicado: (2021)

Addressing TB-related mortality in adults living with HIV: a review of the challenges and potential solutions
por: Sullivan, Amanda, et al.
Publicado: (2022)

Epistemic modesty, ostentatiousness and the uncertainties of epigenetics: on the knowledge machinery of (social) science
por: Pickersgill, Martyn
Publicado: (2016)

Living well in the Neuropolis
por: Fitzgerald, Des, et al.
Publicado: (2016)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

A Plea for Keener Observation, More Conservatism and a Better Understanding of the Question, “Which Is the Best Alloy?”
por: Ward, Marcus L.
Publicado: (1908)

Diabetic Retinopathy: Battling the Global Epidemic
por: Das, Arup
Publicado: (2016)

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop
por: Nair, Prashant, et al.
Publicado: (2016)

Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
por: Csaky, Karl, et al.
Publicado: (2018)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Opportunities from the Center for Perioperative Education
Publicado: (2006)

Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies
por: Levin, Leonard A., et al.
Publicado: (2021)

Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
por: Levine, S. Robert, et al.
Publicado: (2023)

Application and planning of an energy-oriented stochastic disassembly line balancing problem
por: Zhang, Xuesong, et al.
Publicado: (2023)

The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
por: Low, Jia Li, et al.
Publicado: (2019)

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)
por: Yamada, Tadaaki, et al.
Publicado: (2020)

A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study
por: Ikeda, Satoshi, et al.
Publicado: (2020)

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
por: Cinausero, Marika, et al.
Publicado: (2019)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer
por: Farid, Saira, et al.
Publicado: (2020)

Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis
por: Bilani, Nadeem, et al.
Publicado: (2021)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Li, Teng, et al.
Publicado: (2021)

Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
por: Gristina, Valerio, et al.
Publicado: (2021)

A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)
por: Shibaki, Ryota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqaapda7qms3flka06ci6lgs5t